 Patients undergo intensity-modulated radiation therapy IMRT 5 times per week for 7 weeks, receive cisplatin intravenously IV once weekly for 7 weeks, and entolimod subcutaneously SC on days 1, 8, 15, 22, 29, 36, and 43. 